Food and Staples Retailing
Company Overview of Alliance Boots GmbH
Alliance Boots GmbH engages in pharmacy-led health and beauty retailing, and pharmaceutical wholesale and distribution businesses. The company operates and franchises health and beauty retail stores in the United Kingdom, Norway, Ireland, the Netherlands, Lithuania, Thailand, and the Middle East. It also provides contract manufacturing services for consumer health and beauty products, as well as special prescription medicines for individual use in the United Kingdom; skincare and cosmetic brands in France; and color cosmetics in Germany. In addition, the company operates optical and hearing care practices; supplies medicines, other healthcare products, and related services to pharmacies, doc...
Founded in 2006
Key Executives for Alliance Boots GmbH
Chief Executive Officer of Pharmaceutical Wholesale Division
Director of Internal Audit and Risk Management
Human Resources Director of Health and Beauty Division
Compensation as of Fiscal Year 2013.
Alliance Boots GmbH Key Developments
Alliance Boots GmbH Announces Audited Consolidated Earnings Results for the Year Ended March 31, 2013
May 15 13
Alliance Boots GmbH announced audited consolidated earnings results for the year ended March 31, 2013. For the year, the company reported revenue of $22,406 million against $23,009 million a year ago. Profit from operations before associates and joint ventures were $1,054 million against $1,033 million a year ago. Profit before tax was $837 million against $688 million a year ago. Profit for the year from continuing operations was $741 million against $650 million a year ago. Profit for the year attributable to equity shareholders of the company was $707 million against $571 million a year ago. Net cash from operating activities was $1,534 million against $1,518 million a year ago. Purchase of property, plant and equipment, and intangible assets was $200 million against $262 million a year ago. EBITDA was $1,505 million against $1,440 million a year ago. Underlying profit was $805 million against $714 million a year ago.
Alliance Boots GmbH to Report Fiscal Year 2013 Results on May 15, 2013
May 6 13
Alliance Boots GmbH announced that they will report fiscal year 2013 results at 6:00 AM, Eastern Daylight on May 15, 2013
AmerisourceBergen Corporation Announces Strategic, Long-Term Relationship with Walgreen Co. and Alliance Boots GmbH
Mar 19 13
AmerisourceBergen Corporation announced that it is entering into a strategic, long-term relationship with Walgreen Co. and Alliance Boots GmbH, which will streamline the distribution of pharmaceuticals to Walgreens' stores and leverage global supply chain efficiencies while improving patient access to affordable pharmaceuticals to increase the efficiency of the healthcare system. AmerisourceBergen's new expanded relationship with Walgreens and Alliance Boots includes: a ten-year comprehensive primary pharmaceutical distribution contract with Walgreens; access to generic drugs and related pharmaceutical products through the Walgreens Boots Alliance Development joint venture; and opportunities to accelerate the company's efforts to grow its specialty and manufacturer services businesses domestically and internationally. In furtherance of this new partnership, Walgreens and Alliance Boots together have been granted rights to purchase an equity position in AmerisourceBergen. The new agreements are expected to be meaningfully accretive to AmerisourceBergen's earnings and strengthen its confidence in delivering solid and sustainable long-term EPS growth. The ten-year comprehensive primary pharmaceutical supply agreement includes the distribution of brand, generic, and specialty pharmaceuticals to Walgreens' retail stores, mail order and specialty pharmacies. The distribution contract is effective September 1, 2013, and initially will include branded pharmaceutical products that Walgreens has historically sourced from distributors and suppliers. Over time, beginning in calendar year 2014, AmerisourceBergen will increasingly assume the distribution of the generic products that Walgreens has historically self-distributed.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|